These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21404632)

  • 1. [The paradigm of abnormal sensory gating in fear extinction as pathophysiology in obsessive-compulsive disorder].
    Shimizu E
    Seishin Shinkeigaku Zasshi; 2011; 113(1):54-9. PubMed ID: 21404632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired P50 suppression in fear extinction in obsessive-compulsive disorder.
    Nanbu M; Kurayama T; Nakazawa K; Matsuzawa D; Komiya Z; Haraguchi T; Ogura H; Hashimoto T; Yoshida S; Iyo M; Shimizu E
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):317-22. PubMed ID: 20035817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of auditory p50 suppression in human fear conditioning and extinction.
    Kurayama T; Nakazawa K; Matsuzawa D; Yoshida S; Nanbu M; Suto C; Shimizu E
    Biol Psychiatry; 2009 Mar; 65(6):495-502. PubMed ID: 18976983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P50 suppression in human discrimination fear conditioning paradigm using danger and safety signals.
    Kurayama T; Matsuzawa D; Komiya Z; Nakazawa K; Yoshida S; Shimizu E
    Int J Psychophysiol; 2012 Apr; 84(1):26-32. PubMed ID: 22251449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on sensory gating in generalized anxiety and obsessive compulsive disorders].
    Xiao ZP; Chen XS; Wang JJ; Tang YX; Zhang TH; Zhang MD; Fan Q; Lou FY; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):169-72. PubMed ID: 20356551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A follow-up study on features of sensory gating P50 in treatment-resistant depression patients.
    Wang Y; Fang YR; Chen XS; Chen J; Wu ZG; Yuan CM; Yi ZH; Hong W; Zhang C; Cao L
    Chin Med J (Engl); 2009 Dec; 122(24):2956-60. PubMed ID: 20137481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficits in auditory P50 inhibition in obsessive-compulsive disorder.
    Hashimoto T; Shimizu E; Koike K; Orita Y; Suzuki T; Kanahara N; Matsuzawa D; Fukami G; Miyatake R; Shinoda N; Fujisaki M; Shirayama Y; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):288-96. PubMed ID: 17884267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensory gating P50 in schizophrenic patients with and without homicide].
    Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
    Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit.
    Milad MR; Furtak SC; Greenberg JL; Keshaviah A; Im JJ; Falkenstein MJ; Jenike M; Rauch SL; Wilhelm S
    JAMA Psychiatry; 2013 Jun; 70(6):608-18; quiz 554. PubMed ID: 23740049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
    Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
    Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P50 sensory gating in panic disorder.
    Ghisolfi ES; Heldt E; Zanardo AP; Strimitzer IM; Prokopiuk AS; Becker J; Cordioli AV; Manfro GG; Lara DR
    J Psychiatr Res; 2006 Sep; 40(6):535-40. PubMed ID: 16616936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
    Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ
    Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fear conditioning in panic disorder: Enhanced resistance to extinction.
    Michael T; Blechert J; Vriends N; Margraf J; Wilhelm FH
    J Abnorm Psychol; 2007 Aug; 116(3):612-7. PubMed ID: 17696717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic effects of cannabis on sensory gating.
    Broyd SJ; Greenwood LM; Croft RJ; Dalecki A; Todd J; Michie PT; Johnstone SJ; Solowij N
    Int J Psychophysiol; 2013 Sep; 89(3):381-9. PubMed ID: 23628289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interoceptive fear conditioning and panic disorder: the role of conditioned stimulus-unconditioned stimulus predictability.
    Acheson DT; Forsyth JP; Moses E
    Behav Ther; 2012 Mar; 43(1):174-89. PubMed ID: 22304889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis.
    Chang WP; Arfken CL; Sangal MP; Boutros NN
    Psychophysiology; 2011 Jul; 48(7):980-92. PubMed ID: 21214588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experiential, and behavioural responses.
    Blechert J; Michael T; Vriends N; Margraf J; Wilhelm FH
    Behav Res Ther; 2007 Sep; 45(9):2019-33. PubMed ID: 17442266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning procedure.
    Nobre MJ; Cabral A; Brandão ML
    Neuroscience; 2010 Dec; 171(4):1152-63. PubMed ID: 20937363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing.
    Scaife JC; Hou RH; Samuels ER; Baqui F; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2007 Jan; 21(1):93-101. PubMed ID: 16533870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.